Publikationen in Zusammenarbeit mit Forschern von Heinrich Heine University Düsseldorf (11)

2021

  1. Harmonisation preserves research resources

    The Lancet Infectious Diseases

2019

  1. Bioprospecting reveals class ω-transaminases converting bulky ketones and environmentally relevant polyamines

    Applied and Environmental Microbiology, Vol. 85, Núm. 2

  2. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

    The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856

2018

  1. Determinants and Prediction of Esterase Substrate Promiscuity Patterns

    ACS Chemical Biology, Vol. 13, Núm. 1, pp. 225-234

  2. Relationships between substrate promiscuity and chiral selectivity of esterases from phylogenetically and environmentally diverse microorganisms

    Catalysts, Vol. 8, Núm. 1

2016

  1. Analysis of plasminogen genetic variants in multiple sclerosis patients

    G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079

2015

  1. Genome-wide significant association with seven novel multiple sclerosis risk loci

    Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855

2014

  1. The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: The neuromodulation appropriateness consensus committee

    Neuromodulation, Vol. 17, Núm. 6, pp. 515-550

2013

  1. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

    Brain, Vol. 136, Núm. 6, pp. 1778-1782

2012

  1. Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects

    Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562

2004

  1. Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping

    Journal of Bacteriology, Vol. 186, Núm. 13, pp. 4228-4237